Eyebet eye/ear/nasal drops: Each ml contains Betamethasone sodium phosphate BP 1 mg
Eyebet is a preparation of betamethasone. Betamethasone is a synthetic, topical corticosteroid. It has anti-allergic, anti-pruritic and anti-inflammatory activity
Short-term treatment of steroid responsive in inflammatory conditions of the eye after clinical exclusion of bacterial, viral or fungal infections. Non-infected inflammatory conditions of the ear or nose.
Dosage & Administration
Adults and children
Eye: 1 or 2 drops to each affected eye every 1 or 2 hours until control is achieved, then the frequency may be reduced.
Ear: 2 or 3 drops to each affected ear every 2 or 3 hours until control is achieved, then the frequency may be reduced.
Nose: 2 or 3 drops instilled into each nostril 2 or 3 times daily.
Hypersensitivity reactions may occur leading to irritation, burning, stinging, itching and dermatitis. Topical corticosteroid use may result in corneal ulceration, increased intraocular pressure leading to optic nerve damage, reduced visual acuity.Intensive or prolonged use of topical corticosteroids may lead to formation of posterior subcapsular cataracts. In those diseases causing thinning of the cornea or sclera, corticosteroid therapy may result in thinning of the globe leading to perforation. Mydriasis, ptosis and epithelial punctate keratitis have also been reported following ophthalmic use of corticosteroids
Topical corticosteroids should never be given for an undiagnosed red eye. Ophthalmic treatment with corticosteroid preparations should not be repeated or prolonged without regular review to exclude raised intraocular pressure, cataract formation or unsuspected infections
Eyebet is contraindicated in - Herpes simplex virus infection of the eye; known sensitivity or allergy to any ingredient; red eye due to unknown causes; viral or fungal infections in the treatment area; tuberculosis, glaucoma etc.
Use in Pregnancy & Lactation
There are no adequate and well controlled studies for pregnant woman. It should not be used extensively in pregnant woman. There is no information available whether it is secreted in the milk or not.
Specific drug interaction studies have not been conducted.
Long-term intensive topical use may lead to systemic effects
Eyebet should be protected from light, store below 25 °C. Keep out of reach of children. Do not use more than 4 weeks after opening
Eyebet eye/ear/nasal drops: Plastic dropper bottle containing 5 ml eye/ear/nasal drops.